| Literature DB >> 32961577 |
Hirokazu Okada1, Norimitsu Uza1, Tomoaki Matsumori1, Shimpei Matsumoto1, Yuya Muramoto1, Sakiko Ota1, Takeharu Nakamura1, Hiroyuki Yoshida1, Tomonori Hirano1, Takeshi Kuwada1, Saiko Marui1, Yuko Sogabe1, Toshihiro Morita1, Nobuyuki Kakiuchi1, Atsushi Mima1, Tatsuki Ueda1, Yoshihiro Nishikawa1, Motoyuki Tsuda1, Takahisa Maruno1, Masahiro Shiokawa1, Ken Takahashi1, Kojiro Taura2, Sachiko Minamiguchi3, Yuzo Kodama4, Hiroshi Seno1.
Abstract
BACKGROUND : Accurate preoperative assessment of the longitudinal extension of perihilar cholangiocarcinoma (PHCC) is essential for treatment planning. Mapping biopsies for PHCC remain challenging owing to technical difficulties and insufficient sample amounts. The aim of this study was to investigate the usefulness of a novel technique for mapping biopsies of PHCC. METHODS : Our novel method focused on a biliary stent delivery system for mapping biopsies. Fifty patients with PHCC undergoing endoscopic transpapillary mapping biopsy using the novel method were reviewed from August 2015 to June 2019. RESULTS : The median number of biopsy samples was six (range 1 - 17), and the rate of adequate sampling was 91.4 % (266 /291). Biopsy from the intrahepatic bile duct was possible in 82.0 % of patients (41 /50), and negative margins were confirmed in the resected specimens from 34 /39 patients who underwent surgery (87.2 %). None of the patients had post-endoscopic retrograde cholangiopancreatography pancreatitis. CONCLUSIONS : With our novel method, accurate assessment of the longitudinal extension of PHCC might be expected with minimal trauma to the duodenal papilla. Thieme. All rights reserved.Entities:
Mesh:
Year: 2020 PMID: 32961577 DOI: 10.1055/a-1248-2138
Source DB: PubMed Journal: Endoscopy ISSN: 0013-726X Impact factor: 10.093